Analysis Shows Drugmakers Lifted Prices 6.6% So Far This Year
According to the Wall Street Journal, a survey of drugs for diseases like cancer and diabetes showed average price rises of 6.6% in 2022 — a "moderate" amount. Meanwhile, some senators are pressing to have the shelf life of short-supply prescription meds raised.